Release Incubated by Arch Venture Partners and Foresite Labs, Xaira has unveiled with an eye-watering $1 billion and Marc Tessier-Lavigne, Ph.D., former chief scientific officer at Genentech ...
Novo Nordisk has reached an agreement to buy Germany’s Cardior Pharmaceuticals for €1.025 billion ($1.1 billion), adding expertise in RNA therapeutics and a heart failure therapy in mid-stage ...
Despite the efforts of some business groups to abolish the Consumer Financial Protection Bureau (CFPB), the U.S. Supreme Court is standing in the way.I… ...